Delphia (USA)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,983
Closed -$328K 86
2023
Q2
$328K Sell
1,983
-348
-15% -$56.2K 0.52% 62
2023
Q1
$361K Buy
2,331
+187
+9% +$30.2K 0.44% 86
2022
Q4
$379K Sell
2,144
-519
-19% -$89.6K 0.44% 83
2022
Q3
$435K Sell
2,663
-3,394
-56% -$574K 0.5% 57
2022
Q2
$1.07M Buy
6,057
+1,857
+44% +$331K 0.74% 15
2022
Q1
$744K Buy
4,200
+870
+26% +$148K 0.56% 34
2021
Q4
$570K Buy
+3,330
New +$545K 0.61% 30

Other funds holding JNJ

Delphia (USA)'s JNJ Position: Q3 2023 in Review

Delphia (USA) sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 1,983 shares — an estimated $328K sold.

Delphia (USA) first reported a position in JNJ in Q4 2021 and held it in 7 quarters. The position peaked at $1.07M in Q2 2022. 3,679 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • Delphia (USA) reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
  • Delphia (USA) sold 1,983 Johnson & Johnson shares in Q3 2023, an estimated $328K.
  • Delphia (USA) first reported a position in Johnson & Johnson in Q4 2021 and held it in 7 quarters.
  • Delphia (USA)'s Johnson & Johnson position peaked at $1.07M in Q2 2022.
  • 3,679 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Delphia (USA)'s 13F filing for Q3 2023, filed 15 Nov 2023.